Advertisement

Forum

pp 1–2 | Cite as

Sequenzierung, Zulassung, Evidenzgenerierung in der modernen Onkologie

Bessere Evidenz durch neue Studientypen
Sektion C

Literatur

  1. 1.
    Grössmann N et al (2019) Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015. Eur J Cancer 110:1–7CrossRefPubMedGoogle Scholar
  2. 2.
    Woodcock J, LaVange LM (2017) Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. N Engl J Med 377:62–70CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2019

Personalised recommendations